Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Executive Record

Brent Saunders

Chief executive: Allergan (14 May 2014 to present)

20commitments announced
7with a clear outcome
5met on time
–rate shown after 15 outcomes

Commitments are credited to the chief executive in office on the day they were announced. Where a deadline fell after the leader left, the entry is marked. Sources for each leadership change: Allergan filing.

Commitments announced under Brent Saunders

Allerganannounced 10 Feb 2020 Launch Abicipar pegol No record found30 Jun 2020
Allerganannounced 5 Nov 2019 Launch Bimatoprost Sustained-Release for the reduction of intraocular pressure No record found30 Jun 2020
Allerganannounced 6 Aug 2019 Launch CoolTone™ body contouring device Late31 Dec 2019
Allerganannounced 6 Aug 2019 Launch ubrogepant No record found30 Jun 2020
Allerganannounced 6 Aug 2019 Launch Bimatoprost Sustained-Release Being checked30 Jun 2020
Allerganannounced 6 Aug 2019 Launch abicipar in the U.S No record found30 Jun 2020
Allerganannounced 29 Jan 2019 Submit a New Drug Application for Bimatoprost SR Met31 Dec 2019
Allerganannounced 30 Oct 2018 Meet with the FDA to discuss ulipristal acetate No record found31 Dec 2018
Allerganannounced 30 Oct 2018 Report results from the MAPLE clinical trial No record found30 Jun 2019
Allerganannounced 30 Oct 2018 File a Biologics License Application for Abicipar No record found30 Jun 2019
Allerganannounced 30 Oct 2018 Initiate Phase 3 clinical trial for Brimonidine DDS No record found31 Dec 2019
Allerganannounced 26 Jul 2018 File for regulatory approval of Abicipar No record found30 Jun 2019
Allerganannounced 26 Jul 2018 Report additional safety data and results from the second Phase 3 study for Bimatoprost SR No record found30 Jun 2019
Allerganannounced 30 Apr 2018 File a New Drug Application for Ubrogepant with the FDA Met31 Dec 2019
Allerganannounced 20 Dec 2016 Close the acquisition of LifeCell Met30 Jun 2017
Allerganannounced 20 Sep 2016 Close the acquisition of Tobira Therapeutics Met31 Dec 2016
Allerganannounced 14 Sep 2016 Close the acquisition of Vitae Pharmaceuticals Met31 Dec 2016
Allerganannounced 6 Apr 2016 Complete 16 regulatory submissions No record found31 Dec 2016
Allerganannounced 12 Feb 2016 Close the acquisition of Allergan plc Withdrawn31 Dec 2016
Allerganannounced 12 Feb 2016 Decide on the potential separation of the innovative and established businesses No record found31 Dec 2018

Is this record wrong, or are you Brent Saunders? Add a statement or ask for a correction.

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.